menu search

CANF / Can-Fite to Present at Dermatology Drug Development Summit Europe on April 6, 2022

Can-Fite to Present at Dermatology Drug Development Summit Europe on April 6, 2022
PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite to Present at Dermatology Drug Development Summit Europe on April 6, 2022 Read More
Posted: Mar 28 2022, 07:00
Author Name: Business Wire
Views: 092069

CANF News  

New Strong Buy Stocks for October 27th

By Zacks Investment Research
October 27, 2023

New Strong Buy Stocks for October 27th

MTRX, OPI, CANF, ENLV and RAIL have been added to the Zacks Rank #1 (Strong Buy) List on October 27, 2023. more_horizontal

Can-Fite (CANF) Up on Namodenoson Progress in Pancreatic Cancer

By Zacks Investment Research
June 14, 2023

Can-Fite (CANF) Up on Namodenoson Progress in Pancreatic Cancer

Can-Fite's (CANF) shares rise 11.4% as it reveals its plans of submitting an investigational new drug application. The idea is to initiate expansion s more_horizontal

All You Need to Know About Can-Fite Biopharma Ltd (CANF) Rating Upgrade to Buy

By Zacks Investment Research
May 10, 2023

All You Need to Know About Can-Fite Biopharma Ltd (CANF) Rating Upgrade to Buy

Can-Fite Biopharma Ltd (CANF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 more_horizontal

Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding

By MarketBeat
May 2, 2023

Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding

Can-Fite BioPharma Ltd. NYSEAMERICAN: CANF is an Israel-based biotechnology firm that develops small-molecule therapeutic treatments for cancers, infl more_horizontal

Can-Fite BioPharma Shares Jump After Piclidenoson Data In Psoriasis Trial

By Benzinga
June 29, 2022

Can-Fite BioPharma Shares Jump After Piclidenoson Data In Psoriasis Trial

Can-Fite BioPharma Ltd (NYSE: CANF) announced topline results from the COMFORT Phase 3 trial of Piclidenoson in more than 400 adults with moderate more_horizontal

Can-Fite to Present at Dermatology Drug Development Summit Europe on April 6, 2022

By Business Wire
March 28, 2022

Can-Fite to Present at Dermatology Drug Development Summit Europe on April 6, 2022

PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite to Present at Dermatology Drug Development Summit Europe on April 6, 2022 more_horizontal

Can-Fite BioPharma Flags Delay In Piclidenoson Data Readout From Psoriasis Study

By Benzinga
March 8, 2022

Can-Fite BioPharma Flags Delay In Piclidenoson Data Readout From Psoriasis Study

Citing unanticipated delay in the collection of study data, Can-Fite BioPharma Ltd (NYSE: CANF) said that the topline data from its Phase 3 Comfort more_horizontal


Search within

Pages Search Results: